Viewpoint: Lessons learned from 2009 H1N1 Influenza-so far

Article

An editorial that examines the current status of H1N1 in the medical setting.

In some cases the children are asymptomatic, but parents want them evaluated anyway. Some come seeking vaccination, but some are fearful about what they perceive as a new, untested vaccine that might harm their child.

Many children are, indeed, suffering from influenza. If this were any other flu season, their parents might be comfortable treating the fever, cough, and aches with antipyretics and fluids, but this year they are afraid.

Here are some things we've learned:

Perhaps this wave of H1N1 influenza A will have passed by the time you read this-just in time to deal with our usual winter viral respiratory season.

DR. MCMILLAN, editor-in-chief of Contemporary Pediatrics, is professor of pediatrics, vice chair for pediatric education, and director of the pediatric residency training program, Johns Hopkins University School of Medicine, Baltimore.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Related Content
© 2025 MJH Life Sciences

All rights reserved.